The attached article from the "Journal of Biomedical Research" casts some serious doubts about the efficacy and safety of iPS cells (ie those being used by CYP).
I feel much safer backing the RGS adipose derived stem cells.
REGENEUS undervalued on comparison BIOSHARES BUY REC, page-3
Add CMB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.130M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1157 | 45.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 1724 | 1 |
View Market Depth
| Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
| CMB (ASX) Chart |
Day chart unavailable